IL proposes bill for Psilocybin Advisory Board
Legislation is being introduced in Illinois to advance the Compassionate Use and Research of Entheogens (CURE) Act, a measure that would create a regulated framework for the manufacture, delivery and therapeutic use of psilocybin and other entheogens. Senate Bill 2772 would establish an Illinois Psilocybin Advisory Board under the Department of Financial and Professional Regulation to study best practices, develop training standards and recommend health and safety regulations ahead of wider implementation of the CURE Act. The broader CURE Act proposal, previously filed as Senate Bill 2184, would also change state criminal laws around psilocybin and require clinical protocols, such as preparatory sessions and post-session integration for patients referred by healthcare professionals for treatment of conditions like PTSD. SB 2772 is currently awaiting committee assignment.